2019-01-01, 2025-12-31, Cardiology, Vascular, Nephrology, Pulmonology, Endocrinology, Oncology, Infectious Disease, Merck MK1242-035 (Heart Failure Reduced Ejection Fraction), Janssen 7030393AFL3002 (Atrial Fibrillation), Guardant Health 02-GI-002 (Colorectal Cancer Screening), Akero AK-US-001-0107 (NASH), Akero AK-US-001-0105 (NASH), Novo Nordisk NNN9351-4553 (NASH), Inventiva 337HNAS20011 (NASH), Kowa K-001-201 (NASH), Pfizer C4591001 (COVID-19), Regeneron R1093-10987-COV-2069 (SARS COV-2), NIAID ACTT-2/ASA01 (COVID-19), Merck MK-8591A-002 (HIV-1), Eli Lilly J2X-MC-PYAH (COVID-19), Eli Lilly J2W-MC-PYAP (COVID-19), Janssen VAC52416BAC3001 (E.coli Vaccine), Ocugen Inc. OCU-002 (COVID-19 Vaccine), Pfizer C4781004 (Influenza), AstraZeneca D3259C00001 (Urticaria), Moderna mRNA-1083-P101 (COVID-19, Influenza), Universal Diagnostics CRC-US-002 (Colorectal Cancer Screening), Regeneron R668-AS-1885 (Asthma), Avillion AV007 (Asthma), DexCom PTL-1000173 (CGM During Pregnancy), Akebia - CKD / HD - Nephrology, Vertex- CKD / HD Nephrology, CSL - CKD / HD